BT-001: Clinical Trials

1 trial of BT-001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow BT-001: new trials by email Literature Review of BT-001 trials Research Report on BT-001

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
BT-001, Pembrolizumab [KEYTRUDA®] - Metastatic Cancer, Soft Tissue Sarcoma
Phase 1 / Phase 2TerminatedTransgene312021-02-252025-11-21

Conditions studied

Carcinoma, Merkel Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Sarcoma (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Vaccinia (1)

Sponsors

Transgene (1)

Countries

Belgium (1)  ·  France (1)